A. Langer

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 101 citations · Full text

Thrombosis, Superiority Trial, Ischemic Stroke +12

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients

Katarina D. Kovacevic, Stefan Greisenegger, A. Langer et al. · Scientific Reports · 2021 · 34 citations · Full text

Oral signs of aging and their clinical significance.

A. Langer · PubMed · 1976 · 32 citations

Bone Disease, Dental Conditions, Aging +14

Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients.

A. Langer, Nishit Singh, Freeman Mr et al. · PubMed · 1995 · 20 citations